Recruitment

Eingeschlossene Patienten: 23.062 (Stand 01. Oktober 2024)
Amgevita® (Adalimumab)232
Benepali® (Etanercept)1226
Cimzia® (Certolizumab)1035
Enbrel® (Etanercept)2872
Erelzi® (Etanercept)559
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)7
Hulio® (Adalimumab)255
Humira® (Adalimumab)2910
Hyrimoz® (Adalimumab)234
Idacio® (Adalimumab)63
Imraldi® (Adalimumab)226
Inflectra™ (Infliximab)17
Jyseleca® (Filgotinib)148
Kevzara® (Sarilumab)223
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)89
Olumiant® (Baricitinib)545
Orencia® (Abatacept)985
Remicade® (Infliximab)762
Remsima® (Infliximab)25
Rinvoq® (Upadacitinib)310
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1377
Ruxience® (Rituximab)1
Simponi® (Golimumab)471
Truxima® (Rituximab)2
Tyenne® (Tocilizumab)29
Xeljanz® (Tofacitinib)396
Yuflyma® (Adalimumab)42
Zessly® (Infliximab)2
Kontrollen6441